Clinical Trial Update: The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of the insulin degludec/liraglutide combination (IDegLira) in Type 2 diabetes, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• IDegLira (insulin degludec/liraglutide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: NOT_YET_RECRUITING